How organizations have pivoted efforts to combat the global COVID-19 pandemic

Many MedTech companies have responded to the overwhelming demand for additional tools to help prevent the spread of COVID-19 and combat the devastating clinical impact of COVID-19, both in the U.S. and around the globe.  The U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) have enabled organizations to leverage the Emergency Use Authorization (EUA) authority to allow specific unapproved medical products or unapproved uses of approved medical products to be used to diagnose, treat, or prevent serious or life-threatening diseases. Join us virtually as we highlight and discuss the experience of medical device companies and physicians that have navigated bringing COVID-19 devices to market in this unique environment and treating patients with COVID-19.